252 related articles for article (PubMed ID: 14770365)
1. [Osteopetrosis, from mouse to man].
Blin-Wakkach C; Bernard F; Carle GF
Med Sci (Paris); 2004 Jan; 20(1):61-7. PubMed ID: 14770365
[TBL] [Abstract][Full Text] [Related]
2. Establishment and characterization of new osteoclast progenitor cell lines derived from osteopetrotic and wild type mice.
Blin-Wakkach C; Breuil V; Quincey D; Bagnis C; Carle GF
Bone; 2006 Jul; 39(1):53-60. PubMed ID: 16503212
[TBL] [Abstract][Full Text] [Related]
3. Chloride channel ClCN7 mutations are responsible for severe recessive, dominant, and intermediate osteopetrosis.
Frattini A; Pangrazio A; Susani L; Sobacchi C; Mirolo M; Abinun M; Andolina M; Flanagan A; Horwitz EM; Mihci E; Notarangelo LD; Ramenghi U; Teti A; Van Hove J; Vujic D; Young T; Albertini A; Orchard PJ; Vezzoni P; Villa A
J Bone Miner Res; 2003 Oct; 18(10):1740-7. PubMed ID: 14584882
[TBL] [Abstract][Full Text] [Related]
4. Study of the nonresorptive phenotype of osteoclast-like cells from patients with malignant osteopetrosis: a new approach to investigating pathogenesis.
Flanagan AM; Sarma U; Steward CG; Vellodi A; Horton MA
J Bone Miner Res; 2000 Feb; 15(2):352-60. PubMed ID: 10703938
[TBL] [Abstract][Full Text] [Related]
5. Hematological defects in the oc/oc mouse, a model of infantile malignant osteopetrosis.
Blin-Wakkach C; Wakkach A; Sexton PM; Rochet N; Carle GF
Leukemia; 2004 Sep; 18(9):1505-11. PubMed ID: 15284856
[TBL] [Abstract][Full Text] [Related]
6. Osteoclast biology: lessons from mammalian mutations.
Marks SC
Am J Med Genet; 1989 Sep; 34(1):43-54. PubMed ID: 2683780
[TBL] [Abstract][Full Text] [Related]
7. A comparison of osteoclast-rich and osteoclast-poor osteopetrosis in adult mice sheds light on the role of the osteoclast in coupling bone resorption and bone formation.
Thudium CS; Moscatelli I; Flores C; Thomsen JS; Brüel A; Gudmann NS; Hauge EM; Karsdal MA; Richter J; Henriksen K
Calcif Tissue Int; 2014 Jul; 95(1):83-93. PubMed ID: 24838599
[TBL] [Abstract][Full Text] [Related]
8. Are nonresorbing osteoclasts sources of bone anabolic activity?
Karsdal MA; Martin TJ; Bollerslev J; Christiansen C; Henriksen K
J Bone Miner Res; 2007 Apr; 22(4):487-94. PubMed ID: 17227224
[TBL] [Abstract][Full Text] [Related]
9. Low-dose busulphan conditioning and neonatal stem cell transplantation preserves vision and restores hematopoiesis in severe murine osteopetrosis.
Askmyr M; Holmberg J; Flores C; Ehinger M; Hjalt T; Richter J
Exp Hematol; 2009 Feb; 37(2):302-8. PubMed ID: 19100677
[TBL] [Abstract][Full Text] [Related]
10. Human osteopetrosis and other sclerosing disorders: recent genetic developments.
de Vernejoul MC; Bénichou O
Calcif Tissue Int; 2001 Jul; 69(1):1-6. PubMed ID: 11685426
[TBL] [Abstract][Full Text] [Related]
11. Lentiviral gene transfer of TCIRG1 into peripheral blood CD34(+) cells restores osteoclast function in infantile malignant osteopetrosis.
Moscatelli I; Thudium CS; Flores C; Schulz A; Askmyr M; Gudmann NS; Andersen NM; Porras O; Karsdal MA; Villa A; Fasth A; Henriksen K; Richter J
Bone; 2013 Nov; 57(1):1-9. PubMed ID: 23907031
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell-Targeted Neonatal Gene Therapy with a Clinically Applicable Lentiviral Vector Corrects Osteopetrosis in
Löfvall H; Rothe M; Schambach A; Henriksen K; Richter J; Moscatelli I
Hum Gene Ther; 2019 Nov; 30(11):1395-1404. PubMed ID: 31179768
[TBL] [Abstract][Full Text] [Related]
13. Grey-lethal mutation induces severe malignant autosomal recessive osteopetrosis in mouse and human.
Chalhoub N; Benachenhou N; Rajapurohitam V; Pata M; Ferron M; Frattini A; Villa A; Vacher J
Nat Med; 2003 Apr; 9(4):399-406. PubMed ID: 12627228
[TBL] [Abstract][Full Text] [Related]
14. Neonatal hematopoietic stem cell transplantation cures oc/oc mice from osteopetrosis.
Johansson M; Jansson L; Ehinger M; Fasth A; Karlsson S; Richter J
Exp Hematol; 2006 Feb; 34(2):242-9. PubMed ID: 16459192
[TBL] [Abstract][Full Text] [Related]
15. Osteopetrosis--multiple pathways for the interception of osteoclast function.
Marks SC
Appl Pathol; 1987; 5(3):172-83. PubMed ID: 3304355
[TBL] [Abstract][Full Text] [Related]
16. Msx2 -/- transgenic mice develop compound amelogenesis imperfecta, dentinogenesis imperfecta and periodental osteopetrosis.
Aïoub M; Lézot F; Molla M; Castaneda B; Robert B; Goubin G; Néfussi JR; Berdal A
Bone; 2007 Nov; 41(5):851-9. PubMed ID: 17878071
[TBL] [Abstract][Full Text] [Related]
17. Towards a better understanding and new therapeutics of osteopetrosis.
Askmyr MK; Fasth A; Richter J
Br J Haematol; 2008 Mar; 140(6):597-609. PubMed ID: 18241253
[TBL] [Abstract][Full Text] [Related]
18. An alternative splicing variant in Clcn7-/- mice prevents osteopetrosis but not neural and retinal degeneration.
Rajan I; Read R; Small DL; Perrard J; Vogel P
Vet Pathol; 2011 May; 48(3):663-75. PubMed ID: 20448277
[TBL] [Abstract][Full Text] [Related]
19. Severe developmental bone phenotype in ClC-7 deficient mice.
Neutzsky-Wulff AV; Sims NA; Supanchart C; Kornak U; Felsenberg D; Poulton IJ; Martin TJ; Karsdal MA; Henriksen K
Dev Biol; 2010 Aug; 344(2):1001-10. PubMed ID: 20599900
[TBL] [Abstract][Full Text] [Related]
20. Osteoclast biology in the osteopetrotic (op) rat.
Marks SC; Popoff SN
Am J Anat; 1989 Dec; 186(4):325-34. PubMed ID: 2589217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
